PDCD1 and osteosarcoma: Previous studies of anti-PD-1 therapy in osteosarcoma (OS) have shown that anti-PD-1 therapy can cause phenotypic metastasis of macrophages from M2 to M1, resulting in regression of OS pulmonary metastasis.